Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC)

E. F. Smit; M. A. Socinski; B. P. Mullaney; S. P. Myrand; E. Powell; P. Lorigan; C. Kaiser; S. C. Guba; N. Thatcher

Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC)

E. F. Smit
, M. A. Socinski
, B. P. Mullaney
, S. P. Myrand
, E. Powell
, P. Lorigan
, C. Kaiser
, S. C. Guba
, N. Thatcher

Department of Physics & Astronomy

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	8030
Journal	Journal of Clinical Oncology
Volume	27
Issue number	15
Publication status	Published - 20 May 2009
Event	45th Annual Meeting of the American-Society-of-Clinical-Oncology - Florida, United States Duration: 29 May 2009 → 2 Jun 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Smit, E. F., Socinski, M. A., Mullaney, B. P., Myrand, S. P., Powell, E., Lorigan, P., Kaiser, C., Guba, S. C., & Thatcher, N. (2009). Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC). Journal of Clinical Oncology, 27(15), Article 8030.

@article{26badf4aeb03454483466bc379a161e5,

title = "Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC)",

author = "Smit, \{E. F.\} and Socinski, \{M. A.\} and Mullaney, \{B. P.\} and Myrand, \{S. P.\} and E. Powell and P. Lorigan and C. Kaiser and Guba, \{S. C.\} and N. Thatcher",

year = "2009",

month = may,

day = "20",

language = "English",

volume = "27",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "15",

note = "45th Annual Meeting of the American-Society-of-Clinical-Oncology ; Conference date: 29-05-2009 Through 02-06-2009",

}

Smit, EF, Socinski, MA, Mullaney, BP, Myrand, SP, Powell, E, Lorigan, P, Kaiser, C, Guba, SC & Thatcher, N 2009, 'Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC)', Journal of Clinical Oncology, vol. 27, no. 15, 8030.

Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC). / Smit, E. F.; Socinski, M. A.; Mullaney, B. P. et al.
In: Journal of Clinical Oncology, Vol. 27, No. 15, 8030, 20.05.2009.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC)

AU - Smit, E. F.

AU - Socinski, M. A.

AU - Mullaney, B. P.

AU - Myrand, S. P.

AU - Powell, E.

AU - Lorigan, P.

AU - Kaiser, C.

AU - Guba, S. C.

AU - Thatcher, N.

PY - 2009/5/20

Y1 - 2009/5/20

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000276606605232&KeyUID=WOS:000276606605232

M3 - Meeting Abstract

SN - 0732-183X

VL - 27

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

M1 - 8030

T2 - 45th Annual Meeting of the American-Society-of-Clinical-Oncology

Y2 - 29 May 2009 through 2 June 2009

ER -

Pharmacogenomic analysis from a phase III study of pemetrexed plus carboplatin (PC) versus etoposide plus carboplatin (EC) in chemonaive patients (pts) with extensive-stage disease small cell lung cancer (ED-SCLC)

UN SDGs

Other files and links

Cite this